CD4 T 细胞与脑髓母细胞瘤的更好的预后相关
Jin Zhang1, Siqi Ren1, Shuting Li1
1Department of Pediatrics, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Frontiers in oncology
|June 27, 2025
概括
脑髓母细胞瘤中CD4 T细胞增加与更好的患者预后相关,特别是在SHH和非WNT/非SHH亚组中. 这些细胞可能代表治疗点,并与瘤相关的巨细胞相互作用.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- T细胞和瘤相关巨细胞 (TAMs) 是脑瘤微环境 (TME) 中的关键免疫细胞.
- 它们在脑髓母细胞瘤 (一个常见的儿科脑瘤) 中的具体作用尚未完全理解.
- 研究这些免疫成分可以揭示预后标志物和治疗点.
研究的目的:
- 为了检查T细胞透到脑髓母细胞瘤组织中的情况.
- 分析T细胞存在与患者临床结果之间的相关性.
- 探索脑髓母细胞瘤中T细胞和TAM之间的关系.
主要方法:
- 分析了72名脑髓母细胞瘤患者的样本,使用多重免疫光染色.
- 检测T细胞标记物和编程死亡1/编程死亡配体1 (PD-1/PD-L1).
- 统计分析,包括斯皮尔曼相关性,以评估免疫细胞,临床特征和预后之间的关系.
主要成果:
- 与非WNT/非SHH相比,SHH亚组的CD4 T细胞显著增加.
- 较高的CD4 T细胞计数与改善的5年无进展存活率 (PFS) 和整体存活率 (OS) 相相关.
- CD4 T细胞与总巨细胞 (Mtotal) 和M1/M2混合表型巨细胞 (Mmix) 呈现正相关性.
结论:
- 增加的CD4 T细胞与脑髓母细胞瘤患者的更好的预后有关.
- CD4 T 细胞可以作为髓母细胞瘤治疗的潜在治疗点.
- CD4 T 细胞和TAMs之间的潜在相互作用需要进一步调查.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458


